Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • COPYRIGHT—S.D.N.Y.: Artist’s copyright infringement and most royalty claims against Sony may not proceed
    • COPYRIGHT—D. Conn.: Dispute over LEGO minifigure painted with copyrighted jacket will proceed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COPYRIGHT—E.D. La.: Rock band The Revivalists’ motion to dismiss copyright infringement lawsuit partly granted
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PATENT—D. Del.: Generic tasimelteon labels did not induce infringement of sleep-disorder treatment patents
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PATENT—Fed. Cir.: Apple wins IPR appeal over speech-recognition systems
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • TRADEMARK—M.D.N.C.: Court dismisses lawsuit against manufacturer Ruger over SFAR sporting rifles
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    IP Law Daily, PATENT—D. Del.: Generic tasimelteon labels did not induce infringement of sleep-disorder treatment patents, (Sep 28, 2026)

    Law Firms Mentioned:McCarter & English, LLP | Shaw Keller LLP
    Organizations Mentioned:Teva Pharmaceuticals U.S.A., Inc. | Vanda Pharmaceuticals Inc.

    By Ravindra Kumar Singh, B.L.

    The generic drug labels warned that nighttime beta-blocker use could reduce tasimelteon’s efficacy but did not affirmatively encourage prescribers to discontinue beta-blockers before treatment.

    Two generic drug manufacturers secured summary jud ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use